TF and neoplasm: There are some hypotheses to explain the activation of the coagulation system in malignancies, many of which involve the tumour-induced activation of platelets, the increased expression of tumour-related intravascular tissue factor (TF), and the upregulation of endogenous inhibitors of fibrinolysis [6].